June 27 – 29, 2023 | Boston, MA
The 4th Cytokine-Based Drug Development Summit returns as the only industry-led event exclusively addressing discovery, translational and reverse translational challenges.
With a focus on IL-2, IL-12, IL-7, and more across oncology, 80+ key decision makers will discuss approaches to understanding and limiting toxicities, how to develop an accurate and reliable preclinical model, as well as lessons learned from clinical development to inform future design principles.
With an exclusive presentation ‘Examining the Cytokine-based Drug Development Landscape‘, by Beacon’s Cytokine lead, Aysha Saeed, this is an opportunity to join your peers and collaboratively create a path to accelerate the development of cytokine-based drugs with wider therapeutic index demonstrating a clinically relevant benefit to patients.
“Cytokines are both exciting and challenging molecules to develop as drugs. The Cytokine-Based Drug Development Summit provides a great opportunity for leaders in the space to share data and exchange ideas on how to realize their potential” – Donald Shaffer, Head of Precision Cytokines & Cell Therapies, Sanofi